版本:
中国

BRIEF-Pfizer announces results from Phase 3 S-TRAC clinical trial

Oct 10 Pfizer Inc :

* Press release - first positive phase 3 results in adjuvant setting for renal cell carcinoma show sutent (sunitinib) extended disease free survival after surgical removal

* First positive phase 3 results in adjuvant setting for renal cell carcinoma show sutent (sunitinib) extended disease free survival after surgical removal

* Says based on results of s-trac, Pfizer is in discussions with global regulatory authorities to determine potential next steps.

* Says adverse events seen in trial were consistent with sutent's known safety profile Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐